Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital

NCT06834997 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Due to an ongoing national shortage of dronabinol, the study is being discontinued. Given the inability to ensure consistent medication availability, continuation of the study would compromise protocol integrity and participant safety.

Conditions

Interventions

Sponsor

Baylor College of Medicine